Skip to main content
OpenTrials

Clinical trial discovery

Find Clinical Trials

Search studies by condition, treatment, location, eligibility, or trial identifier.

Showing 1–18 of 18 trials

Active filters

Clinical trials found

Published and searchable clinical trials

Searching for clinical trials...
Completed

Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer

NCT01015833

Conditions
Adenocarcinoma, Advanced Adult Hepatocellular Carcinoma, Carcinoma, +18 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Providence Hospital Mobile, Alabama, United States
  • Southern Cancer Center PC-Providence Mobile, Alabama, United States
  • Alaska Regional Hospital Anchorage, Alaska, United States
View all 673 locations
View Trial Details
Completed

A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar Carcinoma

NCT02234986

Conditions
Advanced Adult Hepatocellular Carcinoma, Advanced Fibrolamellar Carcinoma
Locations
  • CASI Site 03 San Francisco, California, United States
  • CASI Site 04 Aurora, Colorado, United States
  • CASI Site 02 Boston, Massachusetts, United States
  • Casi Site 01 New York, United States
View Trial Details
Completed

Study of Dalantercept and Sorafenib in Patients With Advanced Hepatocellular Carcinoma

NCT02024087

Conditions
Advanced Adult Hepatocellular Carcinoma
Locations
  • The University of Chicago Medical Center Chicago, Illinois, United States
  • University of Kansas Medical Center (KUMC) Westwood, Kansas, United States
  • Beth Israel Deaconess Medical Center (BIDMC) Boston, Massachusetts, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
View Trial Details
Completed

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer

NCT01010126

Conditions
Adenocarcinoma, Adnexal Diseases, Adult Hepatocellular Carcinoma, +76 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Los Angeles County-USC Medical Center Los Angeles, California, United States
View all 61 locations
View Trial Details
Completed

Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery

NCT02042443

Conditions
Adenocarcinoma, Adult Cholangiocarcinoma, Advanced Adult Hepatocellular Carcinoma, +35 more
Locations
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
  • Anchorage Oncology Centre Anchorage, Alaska, United States
  • Katmai Oncology Group Anchorage, Alaska, United States
View all 295 locations
View Trial Details
Completed

Study of G-202 (Mipsagargin) as Second-Line Therapy Following Sorafenib in Hepatocellular Carcinoma

NCT01777594

Conditions
Adenocarcinoma, Advanced Adult Hepatocellular Carcinoma, Carcinoma, +9 more
Locations
  • Mary Crowley Cancer Research Center Dallas, Texas, United States
  • Oncology Consultants, PA Houston, Texas, United States
  • University of Texas Health Sciences Center at Houston, Memorial Hermann Cancer Center Houston, Texas, United States
  • The University of Texas Health Science Center at San Antonio San Antonio, Texas, United States
View Trial Details
Completed

MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery

NCT01425879

Conditions
Adenocarcinoma, Advanced Adult Hepatocellular Carcinoma, Biliary Tract Diseases, +20 more
Locations
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
View Trial Details
Completed

Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer

NCT01008566

Conditions
Adenocarcinoma, Adult Hepatocellular Carcinoma, Advanced Adult Hepatocellular Carcinoma, +12 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Penn State Hershey Cancer Institute-Clinical Trials Office Hershey, Pennsylvania, United States
View Trial Details
Completed

Everolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular Carcinoma

NCT01488487

Conditions
Adenocarcinoma, Advanced Adult Hepatocellular Carcinoma, Carcinoma, +9 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
  • Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States
View Trial Details
Completed

Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery

NCT00608361

Conditions
Adenocarcinoma, Adult Acute Lymphoblastic Leukemia in Remission, Adult B Acute Lymphoblastic Leukemia, +144 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Los Angeles County-USC Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 23 locations
View Trial Details